– Menarini Group presentó datos iniciales de seguridad y eficacia de los estudios combinados de fase 1b/2 ELEVATE y ELECTRA de ORSERDU® (Elacestrant) en pacientes con cáncer de mama metastásico (mBC) ER+, HER2- en el Simposio sobre cáncer de mama de San Antonio 2023 Los estudios ELEVATE y…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.